Shanghai Pharmaceutical (02607) rose 4 in the afternoontoponlinepoker.43%toponlinepoker, now reported 12toponlinepoker.74 Hong Kong dollars, with a turnover of 87.781 million Hong Kong dollars.
Shanghai Pharmaceutical announced that recently, the company independently developedtoponlinepoker"I031 Tablets" received the "Drug Clinical Trial Approval Notice" approved and issued by the State Food and Drug Administration ("SDA"). It is reported that I031 is a small molecule inhibitor that can inhibit tumor proliferation. Preclinical studies have shown that I031 can inhibit tumor growth in animal models of human tumors.